Fraudulent COVID-19 products
The following table contains companies and products the Food and Drug Administration (FDA) has issued warning letters about that are selling fraudulent products for the prevention, treatment, mitigation, diagnosis, and cure of COVID-19.
FDA warning letters
Date issued
Company name
Product name
03/06/2020
Xephyr LLC dba N-ergetics
Colloidal Silver 1100 PPMExternal Link Disclaimer, Colloidal Silver 500 PPM, Colloidal Silver 30 PPM, Colloidal Silver Advanced 20 PPM
03/06/2020
GuruNanda, LLC
Essential oil products
03/06/2020
Colloidal Vitality LLC
Products labeled to contain silver
03/06/2020
The Jim Bakker Show
Silver Sol LiquidExternal Link Disclaimer and products labeled to contain silver
03/06/2020
Herbal Amy Inc.
Coronavirus ProtocolExternal Link Disclaimer (Coronavirus Boneset Tea, Coronavirus Cell Protection, Coronavirus Core tincture, Coronavirus Immune System, and Elderberry Tincture)
03/06/2020
Quinessence Aromatherapy Ltd
Essential oil products
03/06/2020
Vivify Holistic Clinic
Essential oil and herb products
Timeline
April 30, 2021
The U.S. Food and Drug Administration announced today the approval of a higher dose naloxone hydrochloride nasal spray product to treat opioid overdose.
April 2019
Juul investor Altria has lost $31 billion, almost a third of its market value since the FDA launched a vaping investigation in April (MO)
People
Name
Role
LinkedIn
Further reading
Title
Author
Link
Type
Date
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
News
Title
Author
Date
Publisher
Description
June 11, 2021
news.google.com
Coronavirus News LIVE Updates: Prime Minister Narendra Modi will participate in the Outreach Sessions of the G7 Summit, to be hosted by UK Prime Minister Boris Johnson on 12-13 June.
Grace Dean
June 9, 2021
news.yahoo.com
US states are racing to use up stocks of the Johnson & Johnson vaccine, or send them elsewhere. Public opinion of the shot has soured.
BioSpace Editorial Staff
June 8, 2021
BioSpace
Please check out the biopharma industry's COVID-19 stories that are trending for June 8, 2021.
Mark Terry
June 8, 2021
BioSpace
Unicorn Hunters is a new Internet reality show where startup companies can pitch a group of well-known panelists dubbed the "Circle of Money" which allows for a kind of crowdsourced funding appeal.
Jan Hoffman
May 28, 2021
www.nytimes.com
The survey found big increases over last month in Latinos getting the shot and in unvaccinated people who say they have made an appointment.
Jan Hoffman
May 28, 2021
www.nytimes.com
The survey found big increases over last month in Latinos getting the shot and in unvaccinated people who say they have made an appointment.
U.S. Food and Drug Administration
May 27, 2021
www.prnewswire.com:443
/PRNewswire/ -- Today, the U.S. Food and Drug Administration and the Federal Trade Commission issued warning letters to five companies for illegally selling...
BioSpace
May 24, 2021
BioSpace
Pfizer Inc. announced that the first enrolled subjects have received their immunizations as part of a new study in adults ages 65 or older exploring the coadministration of the company's 20-valent pneumococcal conjugate vaccine candidate following a booster dose of the Pfizer-BioNTech COVID-19 Vaccine, currently authorized by the Food and Drug Administration under an Emergency Use Authorization.
BioSpace
May 18, 2021
BioSpace
Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, today announced that the Institutional Review Board ("IRB") at the University of the West Indies Hospital, in Jamaica has granted approval to commence the study of its sublingual psilocybin formulation ("CYB001") in a Phase II clinical trial for patients suffering with Major Depressive Disorder ("MDD").
Roche
May 18, 2021
www.prnewswire.com:443
/PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its cobas® SARS-CoV-2 Test for use on the widely available, high-throughput cobas®...
Science X staff
May 17, 2021
phys.org
You want to keep Fido or Fluffy safe, so when they need medication, it's important to ask questions and guard against dosing errors, the U.S. Food and Drug Administration says.
Palatin Technologies, Inc.
May 14, 2021
www.prnewswire.com:443
/PRNewswire/ -- Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that...
BioSpace Editorial Staff
May 11, 2021
BioSpace
Please check out the biopharma industry's COVID-19 stories that are trending for May 11, 2021.
Samus Therapeutics, Inc.
May 11, 2021
www.prnewswire.com:443
/PRNewswire/ -- Samus Therapeutics, Inc. ("Samus Therapeutics" or the "Company"), a privately held, Boston-based biopharmaceutical company developing...
May 10, 2021
BioSpace
Amgen Announces Tezepelumab Biologics License Application Submitted To U.S. FDA - read this article along with other careers information, tips and advice on BioSpace
Zimmer Biomet Holdings, Inc.
May 4, 2021
www.prnewswire.com:443
/PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended March 31, 2021. The Company reported...
IANS
May 2, 2021
The Siasat Daily
New York: US-based pharmaceutical major Pfizer's Chief Executive Officer Albert Bourla said that the company's Covid-19 oral antiviral pill, which is in early-stage trials, could be ready by the end of the year, the media reported. According to CNBC, the company, which developed the first authorised Covid-19 vaccine in the US with German drugmaker BioNTech, began
U.S. Food and Drug Administration
April 30, 2021
www.prnewswire.com:443
/PRNewswire/ -- The U.S. Food and Drug Administration announced today the approval of a higher dose naloxone hydrochloride nasal spray product to treat opioid...
BioSpace
April 30, 2021
BioSpace
Tessa Therapeutics Ltd., a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, announced enrollment of 12 patient Pilot cohort of its Phase 2 trial in relapsed / refractory Classical Hodgkin Lymphoma.
Tessa Therapeutics
April 30, 2021
www.prnewswire.com:443
/PRNewswire/ -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological...
SHOW MORE
References
Is a
Company attributes
Parent organization
Number of employees
17,468
Founded date
June 30, 1906
Other attributes
Owner of
Country
Headquarters
Invested in
Jurisdiction
United States of America
Official name
Food and Drug Administration
Short name
FDA
Wikidata ID
